reports
This National Signing Day, Angi Aims to Boost Hiring in the Trades
This National Signing Day, Angi Aims to Boost Hiring in the Trades Angi expands partnership with trades job platform BlueRecruit and launches new scholarship program to raise awareness of the benefits of the trades and help close the labor gap DENVER, May 06, 2024 (GLOBE NEWSWIRE) -- , a leading and comprehensive solution for improving and maintaining homes, today launched several new initiatives in advance of May 7th’s National Signing Day–a day to acknowledge and celebrate students who pursue an undergraduate or graduate trade school training program. Launched today, the Angi Trade Up...
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution ...
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) (TASE: PFLT) declares its monthly distribution for May 2024 of $0.1025 per share, payable on June 3, 2024 to stockholders of record as of May 15, 2024. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodi...
Dorchester Minerals, L.P. Announces First Quarter Results
Dorchester Minerals, L.P. Announces First Quarter Results DALLAS, May 02, 2024 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the quarter ended March 31, 2024 of $18,167,000, or $0.44 per common unit. A comparison of the Partnership’s consolidated results for the quarter ended March 31, 2024 and 2023 are set forth below: Three Months Ended March 31, 2024 2023Operating Revenues $30,979,000 $40,167,000Net Income $18,167,000 $28,070,000Net Income Per Common Unit $0.44 $0.71 The Partnership previously ...
RLJ Lodging Trust Reports First Quarter 2024 Results
BETHESDA, Md.--(BUSINESS WIRE)-- RLJ Lodging Trust (the “Company”) (NYSE: RLJ) today reported results for the three months ended March 31, 2024. Highlights Portfolio Comparable RevPAR of $137.88; an increase of 1.0% from last year Total Revenue of $324.4 million; an increase of 3.1% from last year Net income of $4.7 million Comparable Hotel EBITDA of $88.9 million Adjusted EBITDA of $79.6 million Adjusted FFO per diluted common share and unit of $0.33 Addressed all 2024 debt maturities “Our first quarter RevPAR growth came in line with our expectations given the holid...
Conduent Reports First Quarter 2024 Financial Results
Conduent Reports First Quarter 2024 Financial Results Key Q1 2024 Highlights Revenue: $921MPre-tax Income: $127MAdj. EBITDA Margin(1): 7.5%New business signings ACV(2): $99MNet ARR Activity Metric(2) (TTM): $17M FLORHAM PARK, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Conduent (NASDAQ: CNDT), a global technology-led business process solutions and services company, today announced its first quarter 2024 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “Q1 2024 is a continued reflection of progress in our portfolio performance overlaid by t...
BioXcel Therapeutics to Report First Quarter 2024 Financial Results on...
BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024 NEW HAVEN, Conn., April 25, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets. BioXcel Therapeutics’ management team will also host a conference call and webcast at 8:00 AM ET that day to discuss the Company’s...
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary F...
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting Poster presentation scheduled for June 1, 2024, 1:30-4:30 PM CT /2:30-5:30 PM ET Trial being led by Georgetown University’s Lombardi Comprehensive Cancer Center NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transforma...
AGS to Report First Quarter 2024 Results on Thursday, May 9, 2024
AGS to Report First Quarter 2024 Results on Thursday, May 9, 2024 LAS VEGAS, April 24, 2024 (GLOBE NEWSWIRE) -- PlayAGS, Incorporated (NYSE: AGS) ("AGS" or the "Company") today announced it will release its financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024. The Company will host an investor conference call and live the same day at 5 p.m. EDT to further discuss its first quarter financial performance. The Company encourages participants to pre-register for the conference call by using the following link: . Callers who pre-regist...
BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-H...
BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential Company plans to initiate SERENITY At-Home pivotal Phase 3 safety trial with 120 mcg dose following recent meeting with FDA No FDA-approved therapies for acute treatment of agitation associated with bipolar disorders or schizophrenia in the home setting NEW HAVEN, Conn., April 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-...
Dorchester Minerals, L.P. Announces Its First Quarter Distribution
Dorchester Minerals, L.P. Announces Its First Quarter Distribution DALLAS, April 18, 2024 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (NASDAQ:DMLP) announced today the Partnership’s first quarter 2024 cash distribution. The distribution of $0.781837 per common unit represents activity for the three-month period ended March 31, 2024 and is payable on May 9, 2024 to common unitholders of record as of April 29, 2024. Cash receipts attributable to the Partnership’s Royalty Properties during the first quarter totaled approximately $24.5 million. Approximately 71% of these receipts reflect o...
Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Co...
Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Conference Call on May 8th DENVER, April 16, 2024 (GLOBE NEWSWIRE) -- After the close of market trading on Tuesday, May 7, 2024, Angi Inc. (NASDAQ: ANGI) will post its first quarter results at . On Wednesday May 8, 2024, at 8:30 a.m. ET, Angi Inc. and IAC will host a conference call to answer questions regarding the companies’ respective first quarter results. The live audiocast and replay will be open to the public through the investor relations section of the Angi site at . About Angi Inc. Angi (NASDAQ: ANGI) helps...
Walgreens Boots Alliance Inc: 1 director
A director at Walgreens Boots Alliance Inc maiden bought 3,000 shares at 18.050USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
Moody's Ratings affirms PENN Entertainment's B1 CFR, outlook stable
Moody's Ratings today affirmed PENN Entertainment, Inc.'s ("PENN") B1 Corporate Family Rating and B1-PD Probability of Default Rating. Moody's Ratings also affirmed the Ba3 rating on PENN's senior secured revolving credit facility, senior secured term loan A, and secured term loan B, as well as the ...
Moody's Ratings affirms PENN Entertainment's B1 CFR, outlook stable
Moody's Ratings today affirmed PENN Entertainment, Inc.'s ("PENN") B1 Corporate Family Rating and B1-PD Probability of Default Rating. Moody's Ratings also affirmed the Ba3 rating on PENN's senior secured revolving credit facility, senior secured term loan A, and secured term loan B, as well as the ...
BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Tri...
BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia Company plans to initiate trial following recent meeting with FDA No FDA-approved therapies for acute treatment of AAD are currently available NEW HAVEN, Conn., April 10, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced details regarding the planned design of its upcoming TRANQUIL...
Angi Appoints Jeff Kip as CEO
Angi Appoints Jeff Kip as CEO DENVER, April 08, 2024 (GLOBE NEWSWIRE) -- Angi (NASDAQ: ANGI), the leading and most comprehensive solution for all home care needs, today announced the appointment of Angi President and long-time IAC and Angi executive Jeff Kip to CEO, succeeding Joey Levin. As CEO, Mr. Kip will lead Angi’s executive team, overseeing strategy and daily management of the company. Mr. Levin, CEO of IAC, will continue as Chairman of the Angi Board of Directors. All changes are effective immediately. “Through multiple roles, Jeff Kip has been a student of the Angi business, fir...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.